Search Results - "Medler, Christoph"

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma by Hess, Georg, Wagner, Karola, Keller, Ulrich, La Rosee, Paul, Atta, Johannes, Hübel, Kai, Lerchenmueller, Christian, Schoendube, Daniel, Witzens‐Harig, Mathias, Ruckes, Christian, Medler, Christoph, Oordt, Christina, Klapper, Wolfram, Theobald, Matthias, Dreyling, Martin

“…In this phase I/II study, we explored the combination of Temsirolimus with Bendamustine and Rituximab (BeRT) in patients with relapsed or refractory (r/r)…”
Get full text

Temsirolimus in Combination with Bendamustine and Rituximab (BeRT) for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Final Phase I/II Results by Hess, Georg, Karola, Wagner, LaRosee, Paul, Keller, Ulrich, Atta, Johannes, Witzens-Harig, Mathias, Crombé, Anne, Medler, Christoph, Borchmann, Peter, Bitz, Ulrich, Lerchenmüller, Christian, Theobald, Matthias, Dreyling, Martin H.

“…Background: mTOR inhibition has been shown to be effective in various subtypes of malignant lymphomas (Smith et al, JCO 2010). Furthermore, in relapsed MCL a…”
Get full text

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II Trial by Hess, Georg, Keller, Ulrich, Atta, Johannes, Bitz, Ulrich, Lerchenmueller, Christian, Karola, Wagner, Medler, Christoph, Ruckes, Christian, Witzens-Harig, Mathias, Huebel, Kai, LaRosee, Paul, Dreyling, Martin H.

“…Background: mTOR inhibition has been shown to be effective in various subtypes of malignant lymphomas. In relapsed MCL a phase III trial could prove…”
Get full text

Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on An Ongoing Phase I/II Trial by Hess, Georg, Keller, Ulrich, Atta, Johannes, Buske, Christian, Borchmann, Peter, Medler, Christoph, Witzens-Harig, Mathias, Dreyling, Martin H.

“…Abstract 2697 mTOR inhibition has been shown to be effective in various subtypes of malignant lymphomas. Based on a phase III trial in relapsed MCL which…”
Get full text

Effects of pentaerythritol tetranitrate on endothelial function in coronary artery disease: results of the PENTA study by Schnorbus, Boris, Schiewe, Robert, Ostad, Mir Abolfazl, Medler, Christoph, Wachtlin, Daniel, Wenzel, Philip, Daiber, Andreas, Münzel, Thomas, Warnholtz, Ascan

“…Background Pentaerythritol tetranitrate (PETN) differs from other organic nitrates by the lack of tolerance induction and by antioxidative properties. The…”
Get full text

Abstract 412: Pentaerithrityltetranitrate Does Not Deteriorate Endothelial Dysfunction In Patients With Coronary Artery Disease. A Prospective, Randomized, Double-blind, Placebo-controlled, Monocentric Clinical Trial (PENTA) by Schiewe, Robert, Schnorbus, Boris, Ostad, Mir Abolfazl, Medler, Christoph, Wenzel, Philip, Daiber, Andreas, Münzel, Thomas, Warnholtz, Ascan

“…Abstract only Purpose: Chronic nitrate therapy remains controversial in patients with coronary artery disease (CAD) due to induction of tolerance and…”
Get full text